Brazilian aHUS & TMA Study Group

Grupo de estudos brasileiro de SHUa &  MAT

atypical Hemolytic Uremic Syndrome Brazil

Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.
de Holanda MI1, Pôrto LC2, Wagner T3, Christiani LF3, Palma LMP4.
https://www.ncbi.nlm.nih.gov/pubmed/28905254

 
Critical appraisal of eculizumab for atypical hemolytic uremic syndrome.
Palma LM1, Langman CB2.
https://www.ncbi.nlm.nih.gov/pubmed/27110144

 
Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
Laurence J1, Haller H2, Mannucci PM3, Nangaku M4, Praga M5, Rodriguez de Cordoba S6.
https://www.ncbi.nlm.nih.gov/pubmed/27930620